Game-changing Strategies of APAC Pharma Companies
Game-changing Strategies of APAC Pharma Companies
Growing Focus on Specific Therapy Areas and Shift Towards Value-based Delivery Model Expected to Boost Pharma Market
24-Jan-2017
Asia Pacific
$1,500.00
Special Price $1,125.00 save 25 %
Description
Frost & Sullivan has recently completed a comprehensive analysis on the current and future strategic imperatives of game-changing Asia-Pacific (APAC) pharmaceutical companies. The analysis primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing. The study provides key insights on the transforming pharmaceutical value chain, with the adoption of technology and shift towards digitalisation of key processes across drug development and manufacturing. It analyses the dynamics catalysing growth, profiles organisations presenting significant growth opportunities, and outlines innovative industry trends of key participants who play a vital role in the pharmaceutical landscape.
The research covers the top 5 APAC pharmaceutical companies based on their industry position. The companies included in the study are Takeda, Otsuka, Astellas Pharma, Meiji Seika, and Celltrion. These companies are benchmarked across 5 key growth levers, namely, core areas of focus, digital footprint, value chain excellence, strategic collaborations and partnerships, and beyond-the-pill services and solutions.
Highlights of the company profiles include:
• Company snapshot
• Performance analysis (market revenue forecast)
• Portfolio analysis
• Key marketed products and patent expiry
• SWOT analysis
• Strategic analysis of growth levers
Table of Contents
Executive Summary
Key Questions to be Answered
APAC Pharma Ecosystem
5 Big Themes for Innovation in APAC Pharma Companies
Focus on Core Areas
Digital Footprint
Value Chain Excellence
Strategic Collaborations/Alliances or Partnerships
Beyond-the-Pill Services and Solutions
Takeda Company Snapshot
Company Performance Analysis
Company Portfolio Analysis
Top 10 Marketed Products by Patent Expiry
Company SWOT Analysis
Strategic Analysis of Growth Levers
Otsuka Company Snapshot
Company Performance Analysis
Company Portfolio Analysis
Top 10 Marketed Products and Patent Expiry
Company SWOT Analysis
Strategic Analysis of Growth Levers
Astellas Pharma Company Snapshot
Company Performance Analysis
Company Portfolio Analysis
Top 10 Marketed Products and Patent Expiry
Company SWOT Analysis
Strategic Analysis of Growth Levers
Meiji Seika Company Snapshot
Company Performance Analysis
Company Portfolio Analysis
Top 10 Marketed Products
Company SWOT Analysis
Strategic Analysis of Growth Levers
Celltrion Inc. Company Snapshot
Company Performance Analysis
Company SWOT Analysis
Strategic Analysis of Growth Levers
The Last Word
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Popular Topics
No Index | No |
---|---|
Podcast | No |
Author | Aarti Chitale |
WIP Number | 9AB9-00-65-00-00 |
Is Prebook | No |